Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.40%
#2 Pons Pons +35.27%
#3 Purr Purr +33.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.57%
#5 TENDIES TENDIES +28.48%
#6 Starpower Starpower +28.34%
#7 StonkBroker StonkBroker +23.34%
#8 SkyAI SkyAI +23.33%
#9 PondCoin PondCoin +22.89%
#10 Magma Finance Magma Finance +22.43%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Helyezés a részvények között #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Részvényárfolyam
$152.40
Piaci kapitalizáció
$376.40B
Változás (1 nap)
12.48%
Változás (1 év)
79.44%
Ország
US
Kereskedés Merck & Co., Inc. (MRK)

Kategória

Healthcare
Merck & Co., Inc. (MRK) P/S aránya
P/S arány ekkor: August 2026 TTM: 5.05
Merck & Co., Inc. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi árbevétel aránya (P/S, TTM) 5.05. 2024 végén ez az arány 3.93 volt.
P/S arány története a(z) Merck & Co., Inc. esetén 2000 és 2026 között
P/S arány az év végén
Év P/S arány Változtassa meg
2026 (TTM) 5.05 24.45%
2025 4.06 3.42%
2024 3.93 -16.98%
2023 4.73 -0.22%
2022 4.74 19.03%
2021 3.98 -16.24%
2020 4.75 -16.41%
2019 5.69 27.31%
2018 4.47 23.86%
2017 3.61 -6.97%
2016 3.88 9.28%
2015 3.55 -2.53%
2014 3.64 14.68%
2013 3.17 26.92%
2012 2.50 9.87%
2011 2.28 -1.64%
2010 2.31 -13.63%
2009 2.68 3.16%
2008 2.60 -47.76%
2007 4.97 24.28%
2006 4.00 32.11%
2005 3.03 2.25%
2004 2.96 -32.43%
2003 4.38 -22.89%
2002 5.68 -6.12%
2001 6.05 18.63%
2000 5.10 0.00%
P/S arány hasonló vállalatoknál vagy versenytársaknál
Vállalat P/S arány P/S arány különbség Ország
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.95 176.11%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.41 26.80%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
6.85 35.47%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -7.81%
CH
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 9.26%
CH